Quiz Summary
0 of 10 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 10 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 10
1. Question
1. In the United States, what is the incidence of calciphylaxis in patients with ESKD on dialysis?
-
Question 2 of 10
2. Question
2. Which of the following is the most common site of calciphylaxis skin lesions?
-
Question 3 of 10
3. Question
3. A patient with more advanced, severe skin lesions is most likely to present with
-
Question 4 of 10
4. Question
4. Carboxylated MGP inhibits which of the following, leading to inhibition of vascular calcification?
-
Question 5 of 10
5. Question
5. Which of the following is not considered a risk factor for developing calciphylaxis?
-
Question 6 of 10
6. Question
6. Which of the following agents are not routinely discontinued should a patient develop calciphylaxis?
-
Question 7 of 10
7. Question
7. A patient on nocturnal peritoneal dialysis develops calciphylaxis. Which of the following is the least appropriate dialysis regimen change for them?
-
Question 8 of 10
8. Question
8. Sodium thiosulfate can cause which of the adverse effects?
-
Question 9 of 10
9. Question
9. Hyperbaric oxygen therapy improves oxygenation to hypoxic tissues leading to all of the following except:
-
Question 10 of 10
10. Question
10. What is the estimated mortality for calciphylaxis patients at 1 year?